[Compliance in therapy of schizophrenic patients with neuroleptics--an overview].
In connection with the efforts to improve the prophylaxis against relapse in schizophrenic patients, the topic of non-compliance to therapy with neuroleptics is gaining interest in scientific research. The importance of this problem has been underestimated in the past. Starting with a review of the current state of research, the article provides an overview of the various determinants of compliance. The conclusions made are discussed in terms of optimizing therapy possibilities. Central to this point are less psychopharmacological options but more process- related aspects of the doctor/patient relationship. Fully informed consent of the patient is aimed at; providing him with detailed information on the purposes and the side-effects of neuroleptic therapy is discussed in terms of its consequences regarding compliant behaviour.
Psychiatrische Klinik, Universität München.
C
C
Mayer
M
M
Soyka
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010349:Patient Compliance / Q000523:psychology*; D010353:Patient Education as Topic; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents
Compliance bei der Therapie schizophrener Patienten mit Neuroleptika--eine Ubersicht.